Compound Summary
Compound Information
5072-26-4
Compound Name: | 5072-26-4 |
Compound CID: | 21157 |
Synonyms: | 5072-26-4 BUTHIONINE SULFOXIMINE Buthionine sulphoximine DL-Buthionine-S,R-sulfoximine Butionine sulfoximine More... |
Iupac Name: | 2-amino-4-(butylsulfonimidoyl)butanoic acid |
InChI: | InChI=1S/C8H18N2O3S/c1-2-3-5-14(10,13)6-4-7(9)8(11)12/h7,10H,2-6,9H2,1H3,(H,11,12) |
InChIKey: | KJQFBVYMGADDTQ-UHFFFAOYSA-N |
Canonical Smiles: | CCCCS(=N)(=O)CCC(C(=O)O)N |
Isomeric Smiles: | CCCCS(=N)(=O)CCC(C(=O)O)N |
Molecular Weight: | 222.31 |
Molecular Formula: | C8H18N2O3S |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
5072-26-4
Molecular Weight: | 222.31 |
Molecular Formula: | C8H18N2O3S |
Hydrogen Bond Donor Count: | 3 |
Hydrogen Bond Acceptor Count: | 5 |
Rotatable Bond Count: | 7 |
Heavy Atom Count: | 14 |
Complexity: | 284 |
Synonyms
5072-26-4
| 5072-26-4 | 5072-26-4 |
|---|---|
5072-26-4 |
BUTHIONINE SULFOXIMINE |
Buthionine sulphoximine |
DL-Buthionine-S,R-sulfoximine |
Butionine sulfoximine |
2-Amino-4-(butylsulfonimidoyl)butanoic acid |
Buthionine sulfoxamine |
D,L-Buthionine-(S,R)-sulfoximine |
DL-Buthionine-sulfoximine |
Buthionine-S,R-sulfoximine |
2-Amino-4-(S-butylsulfonimidoyl)butanoic acid |
Butanoic acid, 2-amino-4-(S-butylsulfonimidoyl)- |
DL-Buthionine-(S,R)-sulfoximine |
NSC 381100 |
2-azaniumyl-4-(butylsulfonimidoyl)butanoate |
CHEBI:28714 |
DL-butathionine-(S,R)-sulfoximine |
MFCD00070309 |
NSC326231 |
NSC381100 |
S-butyl-DL-homocysteine (S,R)-sulfoximine |
S-Butyl-DL-homocysteine-S,R-sulfoximine |
2-amino-4-(S-butylsulfonimidoyl)butyric acid |
NSC 326231 |
BRN 2367136 |
Buthione sulfoximine |
71765-30-5 |
DL-Buthionine-S,R-sulfoximine |
l-buthionine (s,r)-sulfoximine |
dl-buthionine (s,r)-sulfoximine |
NSC-381100 |
BSO |
Sulfoximine, S-(3-amino-3-carboxypropyl)-S-butyl- |
Lopac0_000231 |
SCHEMBL62033 |
BSPBio_002464 |
SPECTRUM1505108 |
dl-Buthionine(S,R)-sulfoximine |
CHEMBL1256575 |
CHEMBL1627290 |
DTXSID6044434 |
CHEBI:176510 |
HMS3260P03 |
BCP24029 |
BCP27775 |
Tox21_500231 |
s2433 |
STL328818 |
AKOS022106364 |
CCG-204326 |
DB12870 |
LP00231 |
MCULE-8178742509 |
SDCCGSBI-0050219.P003 |
NCGC00015148-03 |
NCGC00015148-04 |
NCGC00015148-05 |
NCGC00015148-06 |
NCGC00015148-07 |
NCGC00015148-13 |
NCGC00093696-01 |
NCGC00093696-02 |
NCGC00093696-03 |
NCGC00260916-01 |
AS-67962 |
NCI60_002827 |
HY-106376 |
CS-0025687 |
EU-0100231 |
FT-0624379 |
FT-0627738 |
FT-0663956 |
ST51012445 |
DL-Buthionine-sulfoximine, >=99.0% (TLC) |
2-Amino-4-(butylsulfonimidoyl)butanoic acid # |
B 2640 |
C04543 |
SR-01000075713 |
Q5002519 |
SR-01000075713-1 |
2-amino-4-butyl(imino)oxo-??-sulfanylbutanoic acid |
BRD-A04020513-001-01-9 |
D,L-Buthionine-(S,R)-sulfoximine (Butionine sulfoximine) |
Experimental Data
5072-26-4
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | -1 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
5072-26-4
Statistics Data
5072-26-4
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -1 | 1 | 1 |
Statistics Data Visualization
5072-26-4
